Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Weber, M.
Right arrow Articles by Andersen, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber, M.
Right arrow Articles by Andersen, P. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 123, No. 7, 1505-1515, July 2000
© 2000 Oxford University Press

Preserved slow conducting corticomotoneuronal projections in amyotrophic lateral sclerosis with autosomal recessive D90A CuZn-superoxide dismutase mutation

Markus Weber1, Andrew Eisen1, Heather G. Stewart1 and Peter M. Andersen2

1 The Neuromuscular Diseases Unit, Vancouver Hospital and the University of British Columbia, Vancouver, Canada and 2 Department of Neurology, Umeå University Hospital, Umeå, Sweden

Correspondence to: Dr A. Eisen, Neuromuscular Diseases Unit, Vancouver Hospital, 855 West 12th Avenue, Vancouver, British Columbia, Canada V5Z 1M9 E-mail: eisen{at}unixg.ubc.ca

Recently, a subgroup of the amyotrophic lateral sclerosis (ALS) syndrome associated with mutations in the gene encoding the free radical scavenging enzyme CuZn-superoxide dismutase (CuZn-SOD, SOD1) has been identified. Some 67 different mutations have been reported worldwide to date, comprising about one-fifth of familial ALS cases in the populations studied. The autosomal recessively inherited D90A CuZn-SOD mutation has been associated with a very slowly progressive, clinically distinct phenotype, and is neurophysiologically characterized by very slow central motor conduction. It is not known which physiological and/or biochemical mechanisms are responsible for the different clinical course. To delineate ALS associated with this particular CuZn-SOD mutation from ALS without mutations, we performed a detailed neurophysiological study of the corticomotoneuronal function using peristimulus time histograms (PSTHs) in eight ALS patients homozygous for the D90A CuZn-SOD mutation. The results were compared with those obtained in 12 non-hereditary ALS patients and 11 healthy subjects. PSTHs were constructed from three to seven different, voluntarily recruited motor units of the extensor digitorum communis muscle (EDC) in each patient. The onset latency, number of excess bins, duration and synchrony of the primary peak were analysed. All measurements differed significantly between healthy controls and the D90A patients (P < 0.0007). The mean onset latency of the primary peak in D90A patients was 35.3 ms, compared with 24.2 ms for non-hereditary ALS patients and 19.3 ms for normal subjects (P < 0.0000). Delayed primary peaks in the D90A patients were desynchronized and characteristically preceded by a marked suppression phase. This suppression phase was not seen in non-hereditary ALS patients. We conclude that the mainly slow conducting and/or polysynaptic corticomotoneuronal connections are preserved in the D90A homozygous cases, and that the cortical and possibly spinal inhibitory circuitry is preserved. These events may partially protect the motor neurons, slowing down the degenerative process.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BrainHome page
S. Vucic, G. A. Nicholson, and M. C. Kiernan
Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis
Brain, June 1, 2008; 131(6): 1540 - 1550.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M R Turner, A D Osei-Lah, A Hammers, A Al-Chalabi, C E Shaw, P M Andersen, D J Brooks, P N Leigh, and K R Mills
Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS
J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1279 - 1285.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. R. Turner, A. Hammers, A. Al-Chalabi, C. E. Shaw, P. M. Andersen, D. J. Brooks, and P. N. Leigh
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET
Brain, June 1, 2005; 128(6): 1323 - 1329.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. R. Turner, E. A. Rabiner, A. Hammers, A. Al-Chalabi, P. M. Grasby, C. E. Shaw, D. J. Brooks, and P. N. Leigh
[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS
Brain, April 1, 2005; 128(4): 896 - 905.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.